|
Volumn 299, Issue 12, 2008, Pages 1413-1415
|
Contradictory findings ignite questions about blood glucose targets in diabetes
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACARBOSE;
DIAMICRON MR;
EXENDIN 4;
GLUCOSE;
HEMOGLOBIN A1C;
INDAPAMIDE;
INSULIN;
PERINDOPRIL;
PRETERAX;
ROSIGLITAZONE;
SULFONYLUREA;
UNCLASSIFIED DRUG;
CANADA;
CARDIOVASCULAR RISK;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
HUMAN;
MICROANGIOPATHY;
PATIENT MONITORING;
PEER REVIEW;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SHORT SURVEY;
UNITED STATES;
BLOOD;
CLINICAL TRIAL;
MASS MEDIUM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
RISK;
BLOOD GLUCOSE;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
HUMANS;
MASS MEDIA;
PRACTICE GUIDELINES AS TOPIC;
RISK;
|
EID: 41149113875
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.299.12.1413 Document Type: Short Survey |
Times cited : (2)
|
References (0)
|